Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection

Journal of Clinical Investigation

Volumn 103, Issue 12, 1999, Pages 1659-1667

  Le Moine, Alain ^a,b   Flamand, Véronique ^a   Demoor, François Xavier ^a   Noël, Jean Christophe ^b   Surquin, Murielle ^a,b   Kiss, Robert ^a   Nahori, Marie Anne ^c   Pretolani, Marina ^c   Goldman, Michel ^a   Abramowicz, Daniel ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; GRAFT REJECTION; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SKIN ALLOGRAFT; SKIN FIBROSIS;

EID: 0032745544     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5504     Document Type: Article

References (65)

1. Orosz, C.G., and Pelletier, R.P. 1997. Chronic remodeling pathology in grafts. Curr. Opin. Immunol. 9:676-680.
2. Shi, C., 1996. Immunologic basis of transplant-associated arteriosclerosis. Proc. Natl. Acad. Sci. USA. 93:4051-4056.
3. Nagano, H., et al. 1997. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J. Clin. Invest. 100:550-557.
4. Russell, P.S., Chase, C.M., Winn, H.J., and Colvin, R.B. 1994. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma. Transplantation. 57:1367-1371.
5. Russell, P.S., Chase, C.M., Winn, H.J., and Colvin, R.B. 1994. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am. J. Pathol. 144:260-274.
6. Russell, P.S., Chase, C.M., Winn, H.J., and Colvin, R.B. 1994. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J. Immunol. 152:5135-5141.
7. Le Moine, A., et al. 1998. Chronic rejection of MHC class II disparate skin grafts after anti-CD3 therapy: a model of antibody-independent transplant vasculopathy. Transplantation. 66:1537-1544.
8. Kroegel, C., Virchow, J.C., Jr., Luttmann, W., Walker, C., and Warner, J.A. 1994. Pulmonary immune cells in health and disease. I. The eosinophil leucocyte. Eur. Respir. J. 7:519-543.
9. Minshall, E.M., et al. 1997. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 17:326-333.
10. Birkland, T.P., Cheavens, M.D., and Pincus, S.H. 1994. Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts. Arch. Dermatol. Res. 286:312-318.
11. Noguchi, H., Kephart, G.M., Colby, T.V., and Gleich, G.J. 1992. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am. J. Pathol. 140:521-528.
12. Gleich, G.J., and Kita, H. 1997. Bronchial asthma: lessons from murine models. Proc. Natl. Acad. Sci. USA. 94: 1344-1349.
13. Kadin, M., Butmarc, J., Elovic, A., and Wong, D. 1993. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease. Am. J. Pathol. 142:11-16.
14. Tang, H., Sharp, G.C., Peterson, K.P., and Braley-Mullen, H. 1998. IFN-gamma-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil and infiltration in thyroids. J. Immunol. 160:5105-5112.
15. Hogan, S.P., Koskinen, A., Matthaei, K.I., Young, I.G., and Foster, P.S. 1998. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am. J. Respir. Crit. Care Med. 157:210-218.
16. Nakajima, H., et al. 1992. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146:374-377.
17. Sanderson, C.J. 1992. Interleukin-5, eosinophils, and disease. Blood. 79:3101-3109.
18. Foster, P.S., Hogan, S.P., Ramsay, A.J., Matthaei, K.I., and Young, I.G. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
19. Hung, K., et al. 1998. The central role for CD4+ T cells in the antitumor immune response. J. Exp. Med. 188:2357-2368.
20. Cohn, L., Tepper, J.S., and Bottomly, K. 1998. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 161:3813-3816.
21. Smith, J.A., and Bluestone, J.A. 1997. T cell inactivacion and cytokine deviation promoted by anti-CD3 mAbs. Curr. Opin. Immunol. 9:648-654.
22. Reinke, P., et al. 1997. Selective in vivo deletion of alloactivated TH1 cells by OKT3 monoclonal antibody in acute rejection. Immunol. Lett. 57:151-153.
23. Kopf, M., et al. 1996. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 4:15-24.
24. Leo, O., Foo, M., Sachs, D.H., Samelson, L.E., and Bluestone, J.A. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84:1374-1378.
25. Schumacher, J.H., et al. 1988. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J. Immunol. 141:1576-1581.
26. Boirivant, I.M., Fuss, I.J., Chu, A., and Strober, W. 1998. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to IL-4. J. Exp. Med. 188:1929-1939.
27. Ishida, H., et al. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179:305-310.
28. Billingham, R., and Medawar, P.B. 1951. The technique of free skin grafting in mammals. J. Exp. Biol. 28:385-391.
29. Donckier, V., et al. 1995. Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation. 59:1571-1576.
30. Zuany-Amorim, C., et al. 1996. Modulation by IL-10 of antigen-induced IL-5 generation, and CD4+ T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity. J. Immunol. 157:377-384.
31. Romani, B.L., et al. 1992. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med. 176:19-25.
32. Kopf, M., et al. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 362:245-248.
33. Kopf, M., et al. 1996. IL-4-deficient Balb/c mice resist infection with Leishmania major. J. Exp. Med. 184:1127-1136.
34. Lei, X.F., et al. 1998. Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice. J. Clin. Invest. 101:1342-1353.
35. Viola, J.P.B., Kiani, A., Bozza, P.T., and Rao, A. 1998. Regulation of allergic inflammation and eosinophil recruitment in mice lacking the transcription factor NFAT1: role of interleukin-4 (IL-4) and IL-5. Blood. 91:2223-2230.
36. Ying, S., et al. 1997. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Immunol. 158:5050-5057.
37. Gonzalo, J.A., et al. 1996. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J. Clin. Invest. 98:2332-2345.
38. Natarajan, R., Rosdahl, J., Gonzales, N., and Bai, W. 1997. Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells. Hypertension. 30:873-879.
39. Li, H., Cybulsky, M.I., Grimbone, M.A., and Libby, P. 1993. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am. J. Pathol. 143:1551-1559.
40. Russell, P.S., Chase, C.M., and Colvin, R.B. 1995. Coronary atherosclerosis in transplanted mouse hearts. Transplantation. 60:724-729.
41. Schüler, T., Qin, Z., Ibe, S., Noben-Trauth, N., and Blankenstein, T. 1999. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J. Exp. Med. 189:803-810.
42. Räisänen-Sokolowski, A., Glysing-Jensen, T., Koglin, J., and Russell, M.E. 1998. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. Am. J. Pathol. 152:359-365.
43. Mottram, P.L., Räisänen-Sokolowski, A., Glysing-Jensen, T., Stein-Oakley, A.N., and Russell, M.E. 1998. Cardiac allografts from IL-4 knockout recipients: assessment of transplant arteriosclerosis and peripheral tolerance. J. Immunol. 161:602-609.
44. Gharaee-Kermani, M., et al. 1998. The role of IL-5 in bleomycin-induced pulmonary fibrosis. J. Leukoc. Biol. 64:657-666.
45. Gleich, G.J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422-436.
46. Noguchi, H., et al. 1991. Tissue eosinophilia and eosinophil degranulation in orbital pseudotumor. Ophthalmology. 98:928-932.
47. Foster, P.F., et al. 1991. Eosinophil cationic protein's role in human hepatic allograft rejection. Hepatology. 13:1117-1125.
48. Coffman, R.L., Seymour, B.W., Hudak, S., Jackson, J., and Rennick, D. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 245:308-310.
49. Mould, A.W., Matthaei, K.I., Young, I.G., and Foster, P.S. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064-1071.
50. Chan, S.Y., DeBruyne, L.A., Goodman, R.E., Eichwald, E.J., and Bishop, D.K. 1995. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation. 59:1155-1161.
51. Kondo, T., et al. 1991. Vascular rejection and graft eosinophilia in rat lung allografts. J. Surg. Res. 51:310-315.
52. Martinez, O.M., et al. 1993. Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation. 55:909-918.
53. de Groen, P.C., Kephart, G.M., Gleich, G.J., and Ludwig, J. 1994. The eosinophil as an effector cell of the immune response during hepatic allograft rejection. Hepatology. 20:654-662.
54. Nolan, C.R., Saenz, K.P., Thomas, C.A., and Murphy, K.D. 1995. Role of the eosinophil in chronic vascular rejection of renal allografts. Am. J. Kidney Dis. 26:634-642.
55. Ten, R.M., Gleich, G.J., Holley, K.E., Perkins, J.D., and Torres, V.E. 1989. Eosinophil granule major basic protein in acute renal allograft rejection. Transplantation. 47:959-963.
56. Sher, A., Coffman, R.L., Hieny, S., Scott, P., and Cheever, A.W. 1990. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc. Natl. Acad. Sci. USA. 87:61-65.
57. Kung, T.T., et al. 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. J. Respir. Cell Mol. Biol. 13:360-365.
58. O'Kane, S., and Ferguson, M.W. 1997. Transforming growth factor beta s and wound healing. Int. J. Biochem. Cell Biol. 29:63-78.
59. Elovic, A.E., et al. 1998. IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils. J. Immunol. 160:6121-6127.
60. Constant, S.L., and Bottomly, K. 1997. Induction of Th1 and Th2 CD4+ T cell response: the alternative approaches. Annu. Rev. Immunol. 15:297-322.
61. Mochizuki, M., Bartels, J., Mallet, A.I., Christophers, E., and Schroder, J.M. 1998. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J. Immunol. 160:60-68.
62. Sanz, M.J., et al. 1998. Human eotaxin induces alpha 4 and beta 2 integrin-dependent eosinophil accumulation in rat skin in vivo: delayed generation of eotaxin in response to IL-4. J. Immunol. 160:3569-3576.
63. Ganzalo, J.A., et al. 1996. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity. 4:1-14.
64. Teixeira, M.M., et al. 1997. Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 100:1657-1666.
65. Ponath, P.D., et al. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437-2448.